Improving medication adherence with Treatment Adherence Therapy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON25257

Enrollment

150

Registered

2011-12-07

Start date

2012-03-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with schizophrenia and poor medication adherence

Interventions

Treatment as usual: Treatment as usual consists of regular outpatient care according to the principles of FACT. TAT: Treatment Adherence Therapy (TAT) has recently been developed by Prof Dr Niels M

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosis schizophrenia according to DSM-IV criteria; 2. Current prescription of an antipsychotic medication; 3. Outpatient and autonomous in collecting and using his ofr her antipsychotic medication; 4. Poor medication adherence.

Exclusion criteria

Exclusion criteria: 1. Unable to follow TAT treatment due to inadequate mastery of the Dutch language, or severe cognitive impairment; 2. Severe substance abuse.

Design outcomes

Primary

Measure	Time frame
The proportion of non-adherent patients based on the Brief Adherence Rating Scale (BARS).	—

Secondary

Measure	Time frame
1. (Re-)hospitalization; 2. Quality of life (MANSA); 3. Functioning (GAF); 4. Therapeutical alliance (HAQ); 5. Psychopathology (BPRS-E); 6. Insight (SAI); 7. Treatment Satisfaction Questionnaire for Medication (TSQM).	—

Contacts

Public ContactM.J. Kikkert

Arkin Academy Klaprozenweg 111

martijn.kikkert@arkin.nl+31 (0)20 5904422

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)